Envestnet Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.8M | Buy |
68,369
+3,676
| +6% | +$703K | ﹤0.01% | 1673 |
|
|
2026
Q1 | $11.9M | Buy |
64,693
+5,874
| +10% | +$1.08M | ﹤0.01% | 1710 |
|
|
2025
Q4 | $10.4M | Buy |
58,819
+5,429
| +10% | +$887K | ﹤0.01% | 1659 |
|
|
2025
Q3 | $7.48M | Sell |
53,390
-2,686
| -5% | -$363K | ﹤0.01% | 1963 |
|
|
2025
Q2 | $7.04M | Buy |
56,076
+3,782
| +7% | +$471K | ﹤0.01% | 1972 |
|
|
2025
Q1 | $7.16M | Buy |
52,294
+5,926
| +13% | +$847K | ﹤0.01% | 1875 |
|
|
2024
Q4 | $7.09M | Sell |
46,368
-135,182
| -74% | -$22.8M | ﹤0.01% | 1871 |
|
|
2024
Q3 | $35.2M | Sell |
181,550
-17,126
| -9% | -$3.58M | 0.01% | 882 |
|
|
2024
Q2 | $46.1M | Sell |
198,676
-19,062
| -9% | -$4.14M | 0.02% | 702 |
|
|
2024
Q1 | $47M | Sell |
217,738
-18,713
| -8% | -$4.38M | 0.02% | 695 |
|
|
2023
Q4 | $61.2M | Sell |
236,451
-62,600
| -21% | -$15.4M | 0.03% | 534 |
|
|
2023
Q3 | $76.9M | Sell |
299,051
-13,824
| -4% | -$3.7M | 0.04% | 449 |
|
|
2023
Q2 | $89.1M | Sell |
312,875
-2,243,708
| -88% | -$668M | 0.04% | 369 |
|
|
2023
Q1 | $90.4M | Buy |
2,556,583
+2,263,120
| +771% | +$626M | 0.04% | 351 |
|
|
2022
Q4 | $81.3M | Sell |
293,463
-12,184
| -4% | -$3.44M | 0.04% | 363 |
|
|
2022
Q3 | $81.6M | Sell |
305,647
-1,633
| -0.5% | -$347K | 0.05% | 324 |
|
|
2022
Q2 | $62.7M | Buy |
307,280
+13,474
| +5% | +$2.75M | 0.04% | 380 |
|
|
2022
Q1 | $61.9M | Buy |
293,806
+75,585
| +35% | +$16.4M | 0.03% | 422 |
|
|
2021
Q4 | $52.4M | Sell |
218,221
-16,128
| -7% | -$4.15M | 0.03% | 480 |
|
|
2021
Q3 | $66.3M | Buy |
234,349
+16,790
| +8% | +$5.5M | 0.04% | 380 |
|
|
2021
Q2 | $75.3M | Buy |
217,559
+4,991
| +2% | +$1.51M | 0.04% | 343 |
|
|
2021
Q1 | $59.5M | Buy |
212,568
+30,362
| +17% | +$8.19M | 0.04% | 368 |
|
|
2020
Q4 | $44.6M | Sell |
182,206
-9,822
| -5% | -$2.53M | 0.03% | 381 |
|
|
2020
Q3 | $54.5M | Buy |
192,028
+12,657
| +7% | +$3.53M | 0.05% | 288 |
|
|
2020
Q2 | $48M | Buy |
179,371
+15,462
| +9% | +$4.65M | 0.05% | 292 |
|
|
2020
Q1 | $51.9M | Buy |
163,909
+5,441
| +3% | +$1.65M | 0.06% | 232 |
|
|
2019
Q4 | $47M | Buy |
158,468
+12,747
| +9% | +$3.54M | 0.05% | 282 |
|
|
2019
Q3 | $33.9M | Buy |
145,721
+7,076
| +5% | +$1.65M | 0.04% | 341 |
|
|
2019
Q2 | $32.4M | Sell |
138,645
-11,445
| -8% | -$2.64M | 0.04% | 324 |
|
|
2019
Q1 | $35.5M | Buy |
150,090
+10,603
| +8% | +$3.34M | 0.05% | 289 |
|
|
2018
Q4 | $42M | Buy |
139,487
+96,953
| +228% | +$30.9M | 0.06% | 211 |
|
|
2018
Q3 | $15M | Sell |
42,534
-13,405
| -24% | -$4.62M | 0.03% | 233 |
|
|
2018
Q2 | $16.2M | Buy |
55,939
+39,486
| +240% | +$11.1M | 0.04% | 223 |
|
|
2018
Q1 | $4.5M | Sell |
16,453
-43,458
| -73% | -$13.5M | 0.01% | 429 |
|
|
2017
Q4 | $19.1M | Buy |
59,911
+2,246
| +4% | +$721K | 0.04% | 244 |
|
|
2017
Q3 | $18.1M | Buy |
57,665
+4,136
| +8% | +$1.22M | 0.04% | 239 |
|
|
2017
Q2 | $14.5M | Buy |
53,529
+2,356
| +5% | +$623K | 0.04% | 283 |
|
|
2017
Q1 | $14M | Buy |
51,173
+5,984
| +13% | +$1.69M | 0.04% | 274 |
|
|
2016
Q4 | $12.8M | Buy |
45,189
+6,691
| +17% | +$1.98M | 0.05% | 282 |
|
|
2016
Q3 | $12.1M | Sell |
38,498
-5,658
| -13% | -$1.68M | 0.05% | 292 |
|
|
2016
Q2 | $10.7M | Buy |
44,156
+2,655
| +6% | +$700K | 0.04% | 355 |
|
|
2016
Q1 | $10.8M | Buy |
41,501
+7,370
| +22% | +$1.95M | 0.05% | 329 |
|
|
2015
Q4 | $10.5M | Sell |
34,131
-11,831
| -26% | -$3.4M | 0.05% | 334 |
|
|
2015
Q3 | $13.4M | Sell |
45,962
-11,084
| -19% | -$3.66M | 0.07% | 248 |
|
|
2015
Q2 | $23M | Sell |
57,046
-5,539
| -9% | -$2.22M | 0.11% | 182 |
|
|
2015
Q1 | $26.4M | Buy |
62,585
+59,766
| +2,120% | +$23.6M | 0.14% | 158 |
|
|
2014
Q4 | $957K | Sell |
2,819
-2,166
| -43% | -$701K | 0.01% | 542 |
|
|
2014
Q3 | $1.65M | Buy |
4,985
+823
| +20% | +$271K | 0.02% | 446 |
|
|
2014
Q2 | $1.31M | Buy |
4,162
+97
| +2% | +$29.2K | 0.01% | 465 |
|
|
2014
Q1 | $1.24M | Sell |
4,065
-40
| -1% | -$12.7K | 0.01% | 400 |
|
|
2013
Q4 | $1.15M | Buy |
4,105
+158
| +4% | +$40.9K | 0.01% | 408 |
|
|
2013
Q3 | $950K | Buy |
3,947
+1,462
| +59% | +$327K | 0.01% | 434 |
|
|
2013
Q2 | $535K | Buy |
+2,485
| New | +$531K | 0.01% | 559 |
|
Other funds holding BIIB
Envestnet Asset Management's BIIB Position: Q2 2026 in Review
Envestnet Asset Management increased its Biogen (BIIB) stake by 5.7% in Q2 2026, buying an estimated $703K and bringing the position to 68,369 shares worth $14.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1673.
Envestnet Asset Management first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $90.4M in Q1 2023. 1,042 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Envestnet Asset Management held 68,369 shares of Biogen worth $14.8M as of Q2 2026.
- Envestnet Asset Management bought 3,676 Biogen shares in Q2 2026, an estimated $703K.
- Biogen made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1673 holding.
- Envestnet Asset Management first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Envestnet Asset Management's Biogen position peaked at $90.4M in Q1 2023.
- 1,042 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.